In-Vitro Diagnostics Business Updates Service - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Business Outlook, 2024 (6 updates)" report has been added to ResearchAndMarkets.com's offering.

In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

• Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
• A comprehensive view of the IVD market with test categories covered and company briefs
• M&A activities, selected partnerships & collaborations, partnership deals, and more
• Industry & region watch to help tailor strategies
• Analysis of news and events and reporting on news not easily available

Key Topics Covered: Sample

Market Analysis: Molecular HLA/Transplant Testing

• Overview of Molecular HLA/Transplant Testing
• Market Outlook
• Regional Market
• Top Company Briefs
• Immucor
• Luminex/Diasorin
• Caredx
• Thermo Fisher Scientific

Executive News Briefing

• Dekfi Diagnostics Appoint New CEO
• Onera Raises $32 Million in Funding
• Cleveland Diagnostics Completes $75 Million in Funding

Financial Highlights: Agilent and Hologic

• Agilent Full Year Fiscal 2023 Sales Up 1.5% in Core Business YOY
• Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023
• Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2023 Quarterly Performance
• Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), Fy 2023 (%)
• Figure: Agilent Fy 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia-Pacific, Europe) (%)
• Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
• Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2023 ($ Millions)
• Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2022 and Fy 2023 ($ Millions)
• Figure: Hologic Geographic Revenue Distribution, by Region (Asia-Pacific, Europe, United States, All Others), Fy 2023 (%)

Diagnostic Market Mergers, Acquisitions, and Partnership Deals

• Mergers and Acquisitions
• Table: Selected Diagnostic Market Mergers and Acquisitions Deals
• Partnerships and Collaborations

Industry Watch

• COVID-19 Update

Region Watch

• India
• Figure: India Real GDP Growth, Inflation Rate (Consumer Prices), 2017-2024
• Figure: India Ivd Market Distribution of Sales, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023 (%)
• Saudi Arabia
• Figure: Saudi Arabia Population Pyramid, 2023 and 2053
• Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (Millions of Barrels)
• Figure: Saudi Arabia Ivd Market Share, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023

Broad-based Company Announcements

• Quidelortho Obtains FDA Nod
• Illumina Plans to Divest Grail
• Roche to Acquire Lumiradx
• Qiagen Expands Footprint with New Regional Headquarters in Middle East

For more information about this report visit https://www.researchandmarkets.com/r/dukhdc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.